The inventory ended with a decline of Rs 35.40 or 2.05% over the Tuesday closing value.
There may even be an oversubscription possibility of 5.3 million shares or 3.4% of fairness, the report stated. The full stake sale may very well be as a lot as 10.2% or 10.6 million, together with oversubscription possibility.
The transaction worth is estimated at Rs 1,717.4 crore ($200 million) for the 6.8% holding, the report stated.
The E-book Working Lead Managers (BRLMs) are Kotak Securities, Jefferies, IIFL Capital, Spark (adviser).
The worth of greenshoe to retain oversubscription is Rs 861 crore or $100 million.JB Chemical substances is a pharmaceutical firm which boasts of various merchandise and dosage types throughout therapeutic classes. It presents merchandise associated to gastroenterology, hypertension, and dermatology and has additionally entered newer therapeutic classes like nephrology, respiratory, virology, diabetes, and Nicotine Alternative Remedy (NRT).Shares of JB Chemical substances have adopted a shedding pattern in 2025 up to now, declining by almost 10%. Its one-year returns stand at 5%.
The inventory is presently buying and selling beneath its 200-day easy transferring common of Rs 1,801 whereas managing to stay above its 50-day SMA of Rs 1,669.
(Disclaimer: Suggestions, solutions, views and opinions given by the specialists are their very own. These don’t symbolize the views of Financial Instances)
